Ischemic preconditioning: Tolerance to hepatic ischemia-reperfusion injury

Histology and Histopathology

Volumn 19, Issue 1, 2004, Pages 281-289

  Serafin A ^a   Fernandez Zabalegui L ^a   Prats, N ^b   Wu, Z Y ^c   Roselló Catafau, Joan ^a   Peralta, C ^a  

^a INST D INVESTIGACIONS B   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Ischemia; Liver; Preconditioning; Reperfusion; Steatosis

Indexed keywords

ADENOSINE; ANTINEOPLASTIC AGENT; DOXORUBICIN; ENDOTHELIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; NITRIC OXIDE DONOR; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; XANTHINE OXIDASE; XANTHINE OXIDASE INHIBITOR;

DEATH; DISEASE ASSOCIATION; ENERGY METABOLISM; FATTY LIVER; HUMAN; LIVER BLOOD FLOW; LIVER FAILURE; LIVER ISCHEMIA; LIVER PROTECTION; LIVER SURGERY; LIVER TRANSPLANTATION; LUNG INJURY; MEDIATOR; MICROCIRCULATION; NEUTROPHIL; REPERFUSION INJURY; REVIEW; SIGNAL TRANSDUCTION; STEATOSIS;

ANIMALS; FATTY LIVER; HUMANS; ISCHEMIA; ISCHEMIC PRECONDITIONING; LIVER; MODELS, BIOLOGICAL; REPERFUSION INJURY;

EID: 1642515017     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (77)

1. Behrns K.E., Tsiotos G.G., DeSouza N.F., Krishna M.K., Ludwig J. and Nagorney D.M. (1998). Hepatic steatosis as a potential risk factor major hepatic resection. J. Gastrointest. Surg. 2, 292-298.
2. Bilzer M. and Gerbes A.L. (2000). Preservation injury of the liver: Mechanisms and novel therapeutic strategies. J. Hepatol. 32, 508-515.
3. Bolli R. (2000). The late phase of preconditioning. Circ. Res. 87, 972-983.
4. Carini R., De Cesaris M.G., Splendore R. and Albano E. (2001a). Stimulation of p38 MAP kinase reduces acidosis and Na(+) overload in preconditioned hepatocytes. FEBS Lett. 491, 180-183.
5. Carini R., De Cesaris M.G., Splendore R., Vay D., Domenicotti C., Nitti M.P., Paola D., Pronzato M.A. and Albano E. (2001b). Signal pathway involved in the development of hypoxic preconditioning in rat hepatocytes. Hepatology 33, 131-139.
6. Carini R., De Cesaris M.G., Splendore R., Domenicotti C., Nitti M.P., Pronzato M.A. and Albano E. (2003). Signal pathway responsible for hepatocyte preconditioning by nitric oxide. Free Radic. Biol. Med. 34, 1047-1055.
7. Carroll R. and Yellon D.M. (1999). Myocardial adaptation to ischaemia: The preconditioning phenomenon. Int. J. Cardiol. 68 (Suppl 1), S93-S101.
8. Clavien P.A., Harvey P.R. and Strasberg S.M. (1992). Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 53, 957-978.
9. Clavien P.A., Yadav S., Sindram D. and Bentley R.C. (2000). Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann. Surg. 232, 155-162.
10. Colletti L.M., Burtch G.D., Remick D.G., Kunkel S.L., Strieter R.M., Guice K.S., Oldham K.T. and Campbell D.A. Jr. (1990a). The production of tumor necrosis factor alpha and the development of a pulmonary capillary injury following hepatic ischemia/reperfusion. Transplantation 49, 268-272.
11. Colletti L.M., Remick D.G., Burtch G.D., Kunkel S.L., Strieter R.M. and Campbell D.A. Jr. (1990b). Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J. Clin. Invest. 85, 1936-1943.
12. Cutrin J.C., Perrelli M.G., Cavalieri B., Peralta C., Rosello-Catafau J. and Poli G. (2002). Microvascular dysfunction induced by reperfusion injury and protective effect of ischemic preconditioning. Free Radic. Biol. Med. 33, 1200-1208.
13. D'Alessandro A.M., Kalayoglu M., Sollinger H.W., Hoffmann R.M., Reed A., Knechtle S.J., Pirsch J.D., Hafez G.R., Lorentzen D. and Belzer F.O. (1991). The predictive value of donor liver biopsies on the development of primary nonfunction after orthotopic liver transplantation. Transplant. Proc. 23, 1536-1537.
14. Downey J.M., Cohen M.V., Ytrehus K. and Liu Y. (1994). Cellular mechanisms in ischemic preconditioning: The role of adenosine and protein kinase C. Ann. NY. Acad. Sci. 723, 82-98.
15. Fan C., Zwacka R.M. and Engelhardt J.F. (1999). Therapeutic approaches for ischemia/reperfusion injury in the liver. J. Mol. Med. 77, 577-592.
16. Fernandez L., Heredia N., Grande L., Gomez G., Rimola A., Marco A., Gelpi E., Rosello-Catafau J. and Peralta C. (2002). Preconditioning protects liver and lung damage in rat liver transplantation: Role of xanthine/xanthine oxidase. Hepatology 36, 562-572.
17. Funaki H., Shimizu K., Harada S., Tsuyama H., Fushida S., Tani T. and Miwa K. (2002). Essential role for nuclear factor kappaB in ischemic preconditioning for ischemia-reperfusion injury of the mouse liver. Transplantation 74, 551-556.
18. Glanemann M., Vollmar B., Nussler A.K., Schaefer T., Neuhaus P. and Menger M.D. (2003). Ischemic preconditioning protects from hepatic ischemia/reperfusion-injury by preservation of microcirculation and mitochondrial redox-state. J. Hepatol. 38, 59-66.
19. Goto M., Takei Y., Kawano S., Nagano K., Tsuji S., Masuda E., Nishimura Y., Okumura S., Kashiwagi T., Fusamoto H. and Kamada T. (1994). Endothelin-1 is involved in the pathogenesis of ischemia/reperfusion liver injury by hepatic microcirculatory disturbances. Hepatology 19, 675-681.
20. Horton A.A. and Fairhurst S. (1987). Lipid peroxidation and mechanisms of toxicity. Crit. Rev. Toxicol. 18, 27-79.
21. Howell J.G., Zibari G.B., Brown M.F., Burney D.L., Sawaya D.E., Olinde J.G., Granger D.N. and McDonald J.C. (2000). Both ischemic and pharmacological preconditioning decrease hepatic leukocyte/endothelial cell interactions. Transplantation 69, 300-303.
22. Huguet C., Gavelli A., Harb J., Roger-Clement R., De Millo D., Lasserre M. and McNamara M.T. (1991). L'ischemie du foie de plus d'une heure est-elle un facteur e gravité des hepatectomies? À propos de 19 cas. Chirurgie 117, 351-356.
23. Huguet C., Gavelli A., Chieco P.A., Bona S., Harb J., Joseph J.M., Jobard J., Gramaglia M. and Lasserre M. (1992). Liver ischemia for hepatic resection: Where is the limit? Surgery 111, 251-259.
24. Ishii S., Abe T., Saito T., Tsuchiya T., Kanno H., Miyazawa M., Suzuki M., Motoki R. and Gotoh M. (2001). Effects of preconditioning on ischemia/reperfusion injury of hepatocytes determined by immediate early gene transcription. J. Hepatobiliary Pancreat. Surg. 8, 461-468.
25. Ito K., Ozasa H., Sanada K. and Horikawa S. (2000). Doxorubicin preconditioning: A protection against rat hepatic ischemia-reperfusion injury. Hepatology 31, 416-419.
26. Iwasaki Y., Tagaya N., Hattori Y., Yamaguchi K. and Kubota K. (2002). Protective effect of ischemic preconditioning against intermittent warm-ischemia-induced liver injury. J. Surg. Res. 107, 82-92.
27. Jaeschke H. (2003). Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. 284, G15-G26.
28. Jaeschke H., Farhood A. and Smith C.W. (1990). Neutrophils contribute to ischemia/reperfusion injury in rat liver in vivo. FASEB J. 4, 3355-3359.
29. Koti R.S., Yang W., Dashwood M.R., Davidson B.R. and Seifalian A.M. (2002). Effect of ischemic preconditioning on hepatic microcirculation and function in a rat model of ischemic reperfusion injury. Liver Transpl. 8, 1182-1191.
30. Kukan M. and Haddad P.S. (2001). Role of hepatocytes and bile duct cells in preservation-reperfusion injury of liver grafts. Liver Transpl. 7, 381-400.
31. Kume M., Yamamoto Y., Saad S., Gomi T., Kimoto S., Shimabukuro T., Yagi T., Nakagami M., Takada Y., Morimoto T. and Yamaoka Y. (1996). Ischemic preconditioning of the liver in rats: Implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J. Lab. Clin. Med. 128, 251-258.
32. Kume M., Yamamoto Y., Yamagami K., Ishikawa Y., Uchinami H. and Yamaoka Y. (2000). Pharmacological hepatic preconditioning: Involvement of 70-kDa heat shock proteins (HSP72 and HSP73) in ischaemic tolerance after intravenous administration of doxorubicin. Br. J. Surg. 87, 1168-1175.
33. Lentsch A.B., Kato A., Yoshidome H., McMasters K.M. and Edwards M.J. (2000). Inflammatory mechanisms and therapeutic strategies for warm hepatic ischemia/reperfusion injury. Hepatology 32, 169-173.
34. Li R.C., Ping P., Zhang J., Wead W.B., Cao X., Gao J., Zheng Y., Huang S., Han J. and Bolli R. (2000). PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am. J. Physiol. 279, H1679-H1689.
35. Lichtman S.N. and Lemasters J.J. (1999). Role of cytokines and cytokine-producing cells in reperfusion injury to the liver. Semin. Liver Dis. 19, 171-187.
36. Matuschak G.M., Rinaldo J.E., Pinski M.R., Gavaler J.S. and Van Thiel D.H. (1987). Effect of end stage liver failure on the incidence and resolution of the adult respiratory distress syndrome. J. Crit. Care 2, 162-173.
37. Maulik N., Sato M., Price B.D. and Das D.K. (1998). An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett. 429, 365-369.
38. Muller M.J., Vollmar B., Friedl H.P. and Menger M.D. (1996). Xanthine oxidase and superoxide radicals in portal triad crossclamping-induced microvascular reperfusion injury of the liver. Free Radic. Biol. Med. 21, 189-197.
39. Murry C.E., Jennings R.B. and Reimer K.A. (1986). Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136.
40. Nolte D., Lehr H.A. and Messmer K. (1991). Adenosine inhibits postischemic leukocyte-endothelium interaction in postcapillary venules of the hamster. Am. J. Physiol. 261, H651-H655.
41. Peralta C., Closa D., Hotter G., Gelpi E., Prats N. and Rosello-Catafau J. (1996). Liver ischemic preconditioning is mediated by the inhibitory action of nitric oxide on endothelin. Biochem. Biophys. Res. Commun. 229, 264-270.
42. Peralta C., Hotter G., Closa D., Gelpi E., Bulbena O. and Rosello-Catafau J. (1997). Protective effect of preconditioning on the injury associated to hepatic ischemia-reperfusion in the rat: Role of nitric oxide and adenosine. Hepatology 25, 934-937.
43. Peralta C., Closa D., Xaus C., Gelpi E., Rosello-Catafau J. and Hotter G. (1998). Hepatic preconditioning in rats is defined by a balance of adenosine and xanthine. Hepatology 28, 768-773.
44. Peralta C., Hotter G., Chosa D., Prats N., Xaus C., Gelpi E. and Rosello-Catafau J. (1999a). The protective role of adenosine in inducing nitric oxide synthesis in rat liver ischemia preconditioning is mediated by activation of adenosine A2 receptors. Hepatology 29, 126-132.
45. Peralta C., Prats N., Xaus C., Gelpi E. and Rosello-Catafau J. (1999b). Protective effect of liver ischemic preconditioning on liver and lung injury induced by hepatic ischemia-reperfusion in the rat. Hepatology 30, 1481-1489.
46. Peralta C., Bulbena O., Bargallo R., Prats N., Gelpi E. and Rosello-Catafau J. (2000). Strategies to modulate the deleterious effects of endothelin in hepatic ischemia-reperfusion. Transplantation 70, 1761-1770.
47. Peralta C., Fernandez L., Panes J., Prats N., Sans M., Pique J.M., Gelpi E. and Rosello-Catafau J. (2001a). Preconditioning protects against systemic disorders associated with hepatic ischemia-reperfusion through blockade of tumor necrosis factor-induced P-selectin up-regulation in the rat. Hepatology 33, 100-113.
48. Peralta C., Bartrons R., Serafin A., Blazquez C., Guzman M., Prats N., Xaus C., Cutillas B., Gelpi E. and Rosello-Catafau J. (2001b). Adenosine monophosphate-activated protein kinase mediates the protective effects of ischemic preconditioning on hepatic ischemia-reperfusion injury in the rat. Hepatology 34, 1164-1173.
49. Peralta C., Bulbena O., Xaus C., Prats N., Cutrin J.C., Poli G., Gelpi E. and Rosello-Catafau J. (2002a). Ischemic preconditioning: A defense mechanism against the reactive oxygen species generated after hepatic ischemia reperfusion. Transplantation 73, 1203-1211.
50. Peralta C., Perales J.C., Bartrons R., Mitchell C., Gilgenkrantz H., Xaus C., Prats N., Fernandez L., Gelpi E., Panes J. and Rosello-Catafau J. (2002b). The combination of ischemic preconditioning and liver Bcl-2 overexpression is a suitable strategy to prevent liver and lung damage after hepatic ischemia-reperfusion. Am. J. Pathol. 160, 2111-2122.
51. Pesonen E.J., Linder N., Raivio K.O., Sarnesto A., Lapatto R., Hockerstedt K., Makisalo H. and Andersson S. (1998). Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 114, 1009-1015.
52. Ricciardi R., Chari R.S., Schaffer B.K., Kim R.D., Shah S.A., Potter M.W., Quarfordt S.H., Callery M.P. and Meyers W.C. (2000). Ischemic preconditioning protects liver grafts via tyrosine kinases. Owen H. Wangensteen Surgical Forum.
53. Ricciardi R., Meyers W.C., Schaffer B.K., Kim R.D., Shah S.A., Wheeler S.M., Donohue S.E., Sheth K.R., Callery M.P. and Chari R.S. (2001a). Protein kinase C inhibition abrogates hepatic ischemic preconditioning responses. J. Surg. Res. 97, 144-149.
54. Ricciardi R., Schaffer B.K., Kim R.D., Shah S.A., Donohue S.E., Wheeler S.M., Quarfordt S.H., Callery M.P., Meyers W.C. and Chari R.S. (2001b). Protective effects of ischemic preconditioning on the cold-preserved liver are tyrosine kinase dependent. Transplantation 72, 406-412.
55. Ricciardi R., Shah S.A., Wheeler S.M., Quarfordt S.H., Callery M.P., Meyers W.C. and Chari R.S. (2002). Regulation of NFkappaB in hepatic ischemic preconditioning. J. Am. Coll. Surg. 195, 319-326.
56. Rosser B.G. and Gores G.J. (1995). Liver cell necrosis: Cellular mechanisms and clinical implications. Gastroenterology 108, 252-275.
57. Rudiger H.A. and Clavien P.A. (2000). A cytotoxic drug against reperfusion injury? Hepatology 31, 533-535.
58. Saito T., Ishii S., Abe T., Tsuchiya T., Kanno H., Miyazawa M., Suzuki M. and Gotoh M. (2001). Effect of preconditioning in the liver against ischemia/reperfusion injury, protection of sinusoidal cells and alterations of gene transcription. Transplant. Proc. 33, 849.
59. Sawaya D.E. Jr., Brown M., Minardi A., Bilton B., Burney D., Granger D.N., McDonald J.C. and Zibari G.B. (1999). The role of ischemic preconditioning in the recruitment of rolling and adherent leukocytes in hepatic venules after ischemia/reperfusion. J. Surg. Res. 85, 163-170.
60. Schmid-Schonbein G.W. (1987). Capillary plugging by granulocytes and the no-reflow phenomenon in the microcirculation. Fed. Proc. 46, 2397-2401.
61. Selzner M. and Clavien P.A. (1999). Resections of liver tumors: Special emphasis on neoadjuvant and adjuvant therapy. In: Malignant Liver Tumors-current and Emerging Therapies. Malden M.A. (ed). Oxford. Blackwell Science. pp 137-149.
62. Serafin A., Rosello-Catafau J., Prats N., Xaus C., Gelpi E. and Peralta C. (2002). Ischemic preconditioning increases the tolerance of fatty liver to hepatic ischemia-reperfusion injury in the rat. Am. J. Pathol. 161, 587-601.
63. Serracino-Inglott F., Habib N.A. and Mathie R.T. (2001). Hepatic ischemia-reperfusion injury. Am. J. Surg. 181, 160-166.
64. Shinoda M., Shimazu M., Wakabayashi G., Tanabe M., Hoshino K. and Kitajima M. (2002). Tumor necrosis factor suppression and microcirculatory disturbance amelioration in ischemia/reperfusion injury of rat liver after ischemic preconditioning. J. Gastroenterol. Hepatol. 17, 1211-1219.
65. Simkhovich B.Z., Przyklenk K. and Kloner R.A. (1998). Role of protein kinase C as a cellular mediator of ischemic preconditioning: A critical review. Cardiovasc. Res. 40, 9-22.
66. Sindram D., Rudiger H.A., Upadhya A.G., Strasberg S.M. and Clavien P.A. (2002). Ischemic preconditioning protects against cold ischemic injury through an oxidative stress dependent mechanism. J. Hepatol. 36, 78-84.
67. Strasberg S.M., Howard T.K., Molmenti E.P. and Hertl M. (1994). Selecting the donor liver: Risk factors for poor function after orthotopic liver transplantation. Hepatology 20, 829-838.
68. Teoh N., Dela Pena A. and Farrell G. (2002). Hepatic ischemic preconditioning in mice is associated with activation of NF-kappaB, p38 kinase, and cell cycle entry. Hepatology 36, 94-102.
69. Teoh N., Leclercq I., Pena A.D. and Farrell G. (2003). Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: Implications for preconditioning. Hepatology 37, 118-128.
70. Todo S., Demetris A.J., Makowka L., Teperman L., Podesta L., Shaver T., Tzakis A. and Starzl T.E. (1989). Primary nonfunction of hepatic allografts with preexisting fatty infiltration. Transplantation 47, 903-905.
71. Tong H., Chen W., Steenbergen C. and Murphy E. (2000). Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ. Res. 87, 309-315.
72. Trevisani F., Colantoni A., Caraceni P. and Van Thiel D.H. (1996). The use of donor fatty liver for liver transplantation: A challenge or a quagmire? J. Hepatol. 24, 114-121.
73. Vajdova K., Smrekova R., Mislanova C., Kukan M. and Lutterova M. (2000). Cold-preservation-induced sensitivity of rat hepatocyte function to rewarming injury and its prevention by short-term reperfusion. Hepatology 32, 289-296.
74. Wyatt D.A., Edmunds M.C., Rubio R., Berne R.M., Lasley R.D. and Mentzer R.M. Jr. (1989). Adenosine stimulates glycolytic flux in isolated perfused rat hearts by A1-adenosine receptors. Am. J. Physiol. 257, H1952-H1957.
75. Yadav S.S., Sindram D., Perry D.K. and Clavien P.A. (1999). Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 30, 1223-1231.
76. Yin D.P., Sankary H.N., Chong A.S., Ma L.L., Shen J., Foster P. and Williams J.W. (1998). Protective effect of ischemic preconditioning on liver preservation-reperfusion injury in rats. Transplantation 66, 152-157.
77. Zapletal C., Maksan S.M., Lehmann T., Guenther L., Fallsehr C., Mehrabi A., Weiss G., Golling M., Gebhard M.M., Herfarth C. and Klar E. (1999). Ischemic preconditioning improves liver microcirculation after ischemia/reperfusion. Transplant. Proc. 31, 3260-3262.